Ludwigshafen, Germany

Thomas Schultz


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Schultz - Innovator in Pharmaceutical Compounds

Introduction

Thomas Schultz is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various medical disorders. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Thomas Schultz holds a patent related to compounds of formula (I) that are designed for pharmaceutical applications. The invention focuses on compounds that can be utilized in treating medical disorders, including diseases of the central nervous system, addiction diseases, and obesity. The patent outlines various structural components and their potential therapeutic uses, emphasizing the importance of these compounds in medical treatments.

Career Highlights

Throughout his career, Thomas Schultz has been associated with Abbott GmbH & Co. KG, a leading company in the pharmaceutical industry. His work at Abbott has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development in the field.

Collaborations

Some of Thomas Schultz's notable coworkers include Wilfried Martin Braje and Sean Colm Turner. Their collaborative efforts have further enhanced the innovative environment at Abbott, leading to advancements in pharmaceutical research.

Conclusion

Thomas Schultz is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various medical conditions. His contributions reflect a commitment to innovation and the advancement of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…